Samsung Biologics Q3 net income up 27 pct. to 56.1 bln won
All News
15:45 October 21, 2020
SEOUL, Oct. 21 (Yonhap) -- Samsung Biologics Co. on Wednesday reported its third-quarter net profit of 56.1 billion won (US$49.5 million), up 27 percent from a year earlier.
The company said in a regulatory filing that operating income for the July-September period rose 139.5 percent on-year to 56.5 billion won. Sales increased 48.6 percent to 274.6 billion won.
(END)
Issue Keywords
Most Liked
-
'Queen of Tears' weaves rich tapestry of Korean contemporary art -
Ateez member Yunho throws first pitch at MLB match between Dodgers, Mets -
N. Korea says Kim guided simulated nuclear counterattack drills for 1st time -
N. Korea calls envisioned U.S. aid to Ukraine 'hallucinogen' -
N. Korea calls on party propaganda officials to work harder
Most Saved
-
'Queen of Tears' weaves rich tapestry of Korean contemporary art -
Experts see possibility of N.K. conducting nuclear test before U.S. presidential vote -
Details of meeting between Yoon, opposition leader undecided: presidential office -
N. Korea says Kim guided simulated nuclear counterattack drills for 1st time -
Looming weekly closure of major hospitals feared to worsen medical service crisis
-
S. Korea eliminated in Olympic football qualifiers as poor defense, undisciplined play prove costly -
10-man S. Korea lose to Indonesia to miss out on Paris Olympic football qualification -
(LEAD) 10-man S. Korea lose to Indonesia to miss out on Paris Olympic football qualification -
Indonesia coach left with mixed feelings after eliminating native S. Korea in Olympic football qualifiers -
ADOR CEO calls conflict with Hybe 'worst experience of my life'
